Targeting peroxisome proliferator-activated receptors: A new strategy for the treatment of cardiac fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting peroxisome proliferator-activated receptors: A new strategy for the treatment of cardiac fibrosis

Published:2021-03 Issue: Volume:219 Page:107702
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Lu Qirong,Guo Pu,Guo Jingchao,Ares Irma,Lopez-Torres Bernardo,Martínez-Larrañaga María-Rosa,Wang Xu,Anadón Arturo,Martínez María-Aránzazu

Funder

Ministerio de Economía, Industria y Competitividad, Gobierno de España

National Natural Science Foundation of China

National Key Research and Development Program of China

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference90 articles.

1. Effects of rosiglitazone (PPAR γ agonist) on the myocardium in non-hypertensive diabetic rats (PPAR γ);Abou Daya;Journal of Diabetes,2015

2. Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling;Bansal;The Journal of Biological Chemistry,2017

3. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension;Behringer;Naunyn-Schmiedeberg’s Archives of Pharmacology,2016

4. The mechanisms of action of PPARs;Berger;Annual Review of Medicine,2002

5. Beetroot and sodium nitrate ameliorate cardiometabolic changes in diet-induced obese hypertensive rats;Bhaswant;Molecular Nutrition & Food Research,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications;Medical Review;2024-07-01

2. Biomimetic Cardiac Fibrotic Model for Antifibrotic Drug Screening;Tissue Engineering Part C: Methods;2023-12-01

3. Yttrium chloride induces ferroptosis in cardiomyocytes via iron accumulation and triggers cardiac lipid peroxidation and inflammation that cause heart adverse events in mice;Ecotoxicology and Environmental Safety;2023-09

4. Hydrolysable tannins as a potential therapeutic drug for the human fibrosis‐associated disease;Drug Development Research;2023-06-29

5. PPAR-δ: A key nuclear receptor in vascular function and remodeling;Journal of Molecular and Cellular Cardiology;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3